InsidersTradesSigma
Vicore Pharma Holding AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the Vicore Pharma Holding AB share price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Vicore Pharma Holding AB has logged 2 insider filings. Market capitalisation: €3.8bn. The latest transaction was reported on 8 July 2026 (Purchase). Among the most active insiders: Yasir Al-Wakeel. All data is free.
2
Insider Decl.
0
Thresholds
€14,989
2 ops.
Buy Volume
·
0 ops.
Sell Volume
33Σ signal
Fundamental score
Ranked 19,606 of 25,899 companies
34.0
score / 100
Value15
Quality53
FCF yld-10.0%
Earn yld-13%
EV/EBITDA·
ROE-47%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 July 2026
Declarations2 total
363 shares@ €13.78990.0015% mcap100.0% of flowDepåbevisFI:csv-bbd56d68340298b4cd4c
Ideal exit: 4 Apr 2027 (T+270)
670 shares@ €14.900.0031% mcap100.0% of flowDepåbevisFI:csv-90937ac96d34791f19f3
Ideal exit: 2 Apr 2027 (T+270)
2 of 2 declarations
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a Swedish biopharmaceutical company focused on developing treatments for respiratory diseases. It is listed on the Stockholm Stock Exchange (XSTO).